ALung Technologies, Inc. develops intra and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its products include Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous blood stream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein. The company serves emphysema, chronic bronchitis, asthma with status asthmaticus, acute respiratory failure, acute respiratory distress syndrome, congestive heart failure with pulmonary edema, neonatal respiratory, and distress syndrome patients, as well as military patients. ALung Technologies, Inc. was founded in 1997 and is based in Pittsburgh, Pennsylvania.
Current Team (11)Update
Senior Vice President – Operations
Vice President – Finance and Administration
Senior Vice President – Regulatory Affairs and Quality
President & COO
Director – Product Development
Senior Vice President – Corporate Development
Funding Rounds (7) - $72.5MUpdate
Board Members and Advisors (6)Update
Angel Investor Group
Investors in early-stage B2B software and businses services companies in the Midwest.
Smithfield Trust Company is a mix of the old and the new. Like the trust companies of an older...
Accelerator Fund makes early stage investments in life sciences companies located in western...
venture capital firm
Birchmere Ventures is an early-stage venture capital firm founded in 1996 with a focus on...
333 East Carson
Pittsburgh, PA 15219